← Back to Search

Brain Stimulation

HD-tDCS for Healthy Subjects (FOKhint Trial)

N/A
Waitlist Available
Research Sponsored by Brooklyn College of the City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy, right-handed adults ages 18-35. English spoken since age 5. Normal or corrected-to-normal vision.
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 weeks
Awards & highlights

FOKhint Trial Summary

This study is evaluating whether brain stimulation can improve memory and metamemory.

FOKhint Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

FOKhint Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Memory Control Advantage Index
Secondary outcome measures
Feeling-of-knowing ratings and their accuracy
semantic recall as assessed by a general knowledge task
semantic recognition as assessed by a general knowledge task

FOKhint Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Active DLPFC during taskExperimental Treatment1 Intervention
HD-tDCS will be applied over the DLPFC at 2mA in a single session for up to 30 min during the memory and metamemory task
Group II: Active DLPFC after taskActive Control1 Intervention
HD-tDCS will be applied over the DLPFC at 2mA in a single session for up to 30 min after the memory and metamemory task and during a filler task.
Group III: Sham DLPFC during taskPlacebo Group1 Intervention
Sham HD-tDCS will be applied over the DLPFC at 2mA in a single session for up to 30 min during the memory and metamemory task
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HD-tDCS
2021
Completed Early Phase 1
~50

Find a Location

Who is running the clinical trial?

Brooklyn College of the City University of New YorkLead Sponsor
7 Previous Clinical Trials
84,043 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
266 Previous Clinical Trials
248,358 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~33 spots leftby Mar 2025